logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
16/05/2025
Mawson Infra Gr (MIGI.US): The Q1 2025 financial report achieved revenue of $13.81 million, lower than the previous value of $18.77 million and expectations of $15.7 million; earnings per share were -$0.02, an improvement from the previous value of -$1.19.
Latest
3 m ago
Dahua Group and other investors have established a technology company with business related to the Internet of Things.
3 m ago
Elderly person with serious illness dies while withdrawing money from bank: Family members say they have reconciled, bank will pay 100,000 yuan.
6 m ago
Goldman Sachs raises its GDP growth forecasts for South Korea and Vietnam in 2025.
6 m ago
Goldman Sachs raised its forecasts for the economic growth of South Korea and Vietnam in 2025, citing reduced U.S. tariff risks. Economists Goohoon Kwon and Andrew Tilton stated in a research report that they have revised South Korea's economic growth forecast from 0.7% to 1.1%. The forecast for Vietnam's economic growth is now 5.5%, up from the previous 5.3%.
7 m ago
Hong Kong stocks surging | Four Rings Pharmaceuticals (00460.HK) up more than 6% as two new drugs independently developed by its subsidiary Xuanzhu Biological for two indications are approved for market listing application.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.